The role of clevidipine in hypertension management: Clinical results;El papel del clevidipino en el tratamiento antihipertensivo: resultados clínicos

Revista Espanola de Anestesiologia y Reanimacion

Volumn 61, Issue 10, 2014, Pages 557-564

  Zuleta Alarcon A ^a   Castellon Larios K ^a   Bergese, S ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Agentes antihipertensivos; Bloqueadores de los canales de calcio; Clevidipino; Crisis hipertensiva; Hipertensi n arterial; Periodo perioperatorio

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CLEVIDIPINE; PYRIDINE DERIVATIVE;

CLINICAL TRIAL (TOPIC); HUMAN; HYPERTENSION; TREATMENT OUTCOME;

CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS AS TOPIC; HUMANS; HYPERTENSION; PYRIDINES; TREATMENT OUTCOME;

EID: 84922271050     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2014.06.006     Document Type: Short Survey

References (37)

1. Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013, 31:1281-1357.
2. James P.A., Oparil S., Carter B.L., Cushman W.C., Dennison-Himmelfarb C., Handler J., et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 2014 5, 311:507-520.
3. Levy J.H., Mancao M.Y., Gitter R., Kereiakes D.J., Grigore A.M., Aronson S., et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: The results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg. 2007, 105:918-925.
4. Deshmukh A., Kumar G., Kumar N., Nanchal R., Gobal F., Sakhuja A., et al. Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol 2011, 108:1277-1282.
5. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
6. Frank Peacock W., Varon J., Ebrahimi R., Dunbar L., Pollack C.V. Clevidipine for severe hypertension in patients with renal dysfunction: A VELOCITY trial analysis. Blood Press Suppl 2011, 1:20-25.
7. Peacock F., Varon J., Ebrahimi R., Dunbar L., Pollack C.V. Clevidipine for severe hypertension in acute heart failure: A VELOCITY trial analysis. Congest Heart Fail 2010, 16:55-59.
8. The Medicines Company Cleviprex® (Clevidipine Butyrate) injectable emulsion: US prescribing information [online] [consultado 11 Ene 2014]. Disponible en:. http://www.cleviprex.com/clev-pdfs/1%2014_Proposed_PI-S-003%20(clean%20ver).pdf.
9. Ericsson H., Fakt C., Jolin-Mellgård A., Nordlander M., Sohtell L., Sunzel M., et al. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol 1999, 47:531-538.
10. Ericsson H., Bredberg U., Eriksson U., Jolin-Mellgård A., Nordlander M., Regårdh C.G. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology 2000, 92:993-1001.
11. Schwieler J.H., Ericsson H., Löfdahl P., Thulin T., Kahan T. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol 1999, 34:268-274.
12. Bailey J.M., Lu W., Levy J.H., Ramsay J.G., Shore-Lesserson L., Prielipp R.C., et al. Clevidipine in adult cardiac surgical patients: A dose-finding study. Anesthesiology 2002, 96:1086-1094.
13. Powroznyk A.V., Vuylsteke A., Naughton C., Misso S.L., Holloway J., Jolin-Mellgård A., et al. Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. Eur J Anaesthesiol 2003, 20:697-703.
14. Singla N., Warltier D.C., Gandhi S.D., Lumb P.D., Sladen R.N., Aronson S., et al. Treatment of acute postoperative hypertension in cardiac surgery patients: An efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg 2008, 107:59-67.
15. Pollack C.V., Varon J., Garrison N.A., Ebrahimi R., Dunbar L., Peacock W.F. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med 2009, 53:329-338.
16. Aronson S., Dyke C.M., Stierer K.A., Levy J.H., Cheung A.T., Lumb P.D., et al. The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 2008, 107:1110-1121.
17. World Health Organization. A global brief on hypertension. Silent killer, global public health crisis. World Health Day 2013. Document number: WHO/DCO/WHD/2013.2 [consultado 21 Ene 2014]. Disponible en: http://apps.who.int/iris/handle/10665/79059.
18. Sierra P., Galcerán J.M., Sabaté S., Martínez-Amenós A., Castaño J., Gil A. Documento de consenso sobre hipertensión arterial y anestesia de las Sociedades Catalanas de Anestesiología e Hipertensión Arterial. Rev Esp Anestesiol Reanim 2009, 56:493-502.
19. Sarafidis P.A., Georgianos P.I., Malindretos P., Liakopoulos V. Pharmacological management of hypertensive emergencies and urgencies: Focus on newer agents. Expert Opin Investig Drugs 2012, 21:1089-1106.
20. Johnson W., Nguyen M.L., Patel R. Hypertension crisis in the emergency department. Cardiol Clin 2012, 30:533-543.
21. National high blood pressure education program. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2004 Aug. [consultado 21 Ene 2014]. Disponible en:. http://www.ncbi.nlm.nih.gov/books/NBK9630/.
22. Ahuja K., Charap M.H. Management of perioperative hypertensive urgencies with parenteral medications. J Hosp Med 2010, 5:E11-E16.
23. Bergese S.D., Puente E.G. Clevidipine butyrate: A promising new drug for the management of acute hypertension. Expert Opin Pharmacother 2010, 11:281-295.
24. Tulman D.B., Stawicki S.P., Papadimos T.J., Murphy C.V., Bergese S.D. Advances in management of acute hypertension: A concise review. Discov Med 2012, 13:375-383.
25. Cada D., Levien T., Baker D. Clevidipine butyrate injectable emulsion. Hosp Pharm 2008, 43:903-912.
26. Awad A.S., Goldberg M.E. Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: A review. Vasc Health Risk Manag 2010, 6:457-464.
27. Hassanain H.H., Hassona M.D., Puente E.G., Sun C., Abouelnaga Z.A., Tulman D.B., et al. In vitro assessment of clevidipine using the profilin1 hypertensive mouse model. Pharmaceuticals (Basel) 2013, 6:623-633.
28. Agencia española de medicamentos y productos sanitarios. The Medicines Company Cleviprex® (Clevidipine Butyrate). Modulo 1, 1.3.1.1 Informacion sobre el producto (español). Ficha técnica o resumen de las características del producto [online] [consultado 4 May 2014]. Disponible en:. http://www.aemps.gob.es/cima/pdfs/es/ft/76595/FT_76595.pdf.
29. UK medicines information. New drugs online reports for Clevidipine [online]. [consultado 4 May 2014]. Disponible en:. http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp%3FnewDrugID=4184.
30. UK medicines information. New drugs online reports for Clevidipine [online]. [consultado 4 May 2014]. Disponible en:. http://www.medicines.org.uk/emc/printfriendlydocument.aspx%3Fdocumentid=28128.
31. Graffagnino C., Bergese S., Love J., Schneider D., Lazaridis C., LaPointe M., et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: The ACCELERATE trial. Cerebrovasc Dis 2013, 36:173-180.
32. Tobias J.D., Allee J., Ramachandran V., Groshong T. Clevidipine controls intraoperative blood pressure in an adolescent with renal failure. J Pediatr Pharmacol Ther 2009, 14:144-147.
33. Tobias J.D., Hoernschemeyer D.G. Clevidipine for controlled hypotension during spinal surgery in adolescents. J Neurosurg Anesthesiol 2011, 23:347-351.
34. Tobias J.D., Tulman D.B., Bergese S.D. Clevidipine for perioperative blood pressure control in infants and children. Pharmaceuticals (Basel) 2013, 6:70-84.
35. Towe E., Tobias J.D. Preliminary experience with clevidipine in the pediatric population. J Intensive Care Med 2010, 25:349-352.
36. Bekker A., Didehvar S., Kim S., Golfinos J.G., Parker E., Sapson A., et al. Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience. J Neurosurg Anesthesiol 2010, 22:330-335.
37. Peacock W.F., Angeles J.E., Soto K.M., Lumb P.D., Varon J. Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: A review. Ther Clin Risk Manag 2009, 5:627-634.